{"id":"NCT03895203","sponsor":"UCB Biopharma SRL","briefTitle":"A Study to Test the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis","officialTitle":"A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Active Reference (Adalimumab) Study Evaluating the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-04-03","primaryCompletion":"2021-08-17","completion":"2022-07-11","firstPosted":"2019-03-29","resultsPosted":"2024-10-23","lastUpdate":"2025-06-22"},"enrollment":852,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Psoriatic Arthritis"],"interventions":[{"type":"DRUG","name":"Bimekizumab","otherNames":["BKZ","UCB4940"]},{"type":"DRUG","name":"Adalimumab","otherNames":["HUMIRAÂ®"]},{"type":"OTHER","name":"Placebo","otherNames":["PBO"]}],"arms":[{"label":"Bimekzumab dosage regimen","type":"EXPERIMENTAL"},{"label":"Adalimumab dosage regimen","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This is a study to demonstrate the clinical efficacy, safety and tolerability of bimekizumab administered subcutaneously (sc) compared with placebo in the treatment of subjects with active Psoriatic Arthritis (PsA).","primaryOutcome":{"measure":"Percentage of Participants With an American College of Rheumatology (ACR) 50 Response at Week 16","timeFrame":"Week 16","effectByArm":[{"arm":"Placebo","deltaMin":10,"sd":null},{"arm":"BKZ 160 mg Q4W","deltaMin":43.9,"sd":null},{"arm":"ADA 40 mg Q2W","deltaMin":45.7,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":8,"exclusionCount":10},"locations":{"siteCount":136,"countries":["United States","Australia","Belgium","Canada","Czechia","France","Germany","Hungary","Italy","Japan","Poland","Russia","Spain","United Kingdom"]},"refs":{"pmids":["37696588","38446397","39534481","40347389","40194794","39892885","39313302","39215949","39120849","39120848","38754125","38488975","38073049","36493791"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":281},"commonTop":["Nasopharyngitis","Upper respiratory tract infection","Urinary tract infection","Oral candidiasis"]}}